Other Categories

Neurologists test novel compound for lung and brain injury in severe COVID-19 patients

Neurologists are researching whether a novel immunomodulatory treatment, OP-101, can dampen lung and brain injury in hospitalized COVID-19 patients through a clinical trial at The University of Texas Health Science Center at Houston (UTHealth).

Read full article

Pregnant Hispanic patients more likely to contract COVID-19 than other racial-ethnic groups
Pregnant Hispanic patients were nearly twice as likely to be diagnosed with COVID-19 than other racial-ethnic groups and most were asymptomatic, according to research by The University of Texas Health Science Center at Houston (UTHealth).

Read more
$5 million NIH grant awarded to reduce COVID-19-related disparities in vulnerable populations
To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston (UTHealth) will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.

Read more
Could the time of day impact the effectiveness of COVID-19 treatment?
For months, experts have warned against the use of anti-inflammatory medications, such as ibuprofen, to treat COVID-19 symptoms. But could the timing of when this drug is taken play a role in its effectiveness?

Read more
Young Houston woman recovers from COVID-19 after participation in two UTHealth clinical trials Heba Hajjar, 23, recovered from COVID-19 after participating in two clinical trials through The University of Texas Health Science Center at Houston (UTHealth) while in the intensive care unit (ICU) at Memorial Hermann-Texas Medical Center. She was so weak she couldn’t move or sit up in bed. She was cautiously monitored on oxygen therapy and […]
Read more
Team is first in Texas to join NIH-sponsored study investigating efficacy of convalescent plasma for COVID-19 Using a multimillion-dollar grant from the National Institutes of Health, physician-scientists at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country. As part of the Center for Clinical and Translational Sciences, […]
Read more
Dear parents – Call your pediatrician After a noticeable dip in immunizations over the last few months, pediatricians are urging parents to schedule important checkups and vaccines.
Read more
Review report outlines rehabilitation strategies for COVID-19 patients In a review report published in The Journal of the International Society of Physical and Rehabilitation Medicine, experts explored different interventions and provided a guide on how critically ill patients who have recovered from COVID-19 can rehabilitate and get back to their normal lives.
Read more
Experts warn against hand sanitizers containing methanol Hand sanitizers may help prevent the spread of coronavirus, but experts warn that some may contain a dangerous, hidden ingredient.
Read more
COVID-19 patient at LBJ Hospital recovers after convalescent plasma transfusion More than a month after her battle with COVID-19, Kony Chacon enjoys spending time with newborn daughter and shows no ill effects from the virus that jeopardized her life and that of her unborn child. She credits a century-old treatment now being used to help coronavirus patients fight off the infection – convalescent blood plasma […]
Read more
Researchers study whether vadadustat, an investigational therapy, could mitigate acute lung injury in COVID-19 patients Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at The University of Texas Health Science Center at Houston (UTHealth). Vadadustat is designed to mimic the physiologic response to hypoxia (low oxygen). […]
Read more
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann – Texas Medical Center and Harris Health System’s Lyndon B. Johnson Hospital. The […]
Read more
Simple blood test can predict severity of COVID-19 for some patients An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of […]
Read more
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at The University of Texas Health Science Center at Houston (UTHealth). Convalescent Plasma to Stem Coronavirus will assess whether convalescent […]
Read more
UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital. The Phase III, multisite, randomized, double-blind, […]
Read more
Autopsy research aims to advance COVID-19 knowledge In an effort to continue fighting the global COVID-19 pandemic, a team of pathologists from The University of Texas Health Science Center at Houston (UTHealth) has documented the pathological findings from 23 autopsy patients with the disease in an upcoming issue of Cardiovascular Pathology, now available online. The study collated and summarized the findings of autopsy […]
Read more
Experts at UTHealth successfully treat severe case of COVID-19 in 3-week-old infant In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The case was published April 22 in the New England Journal of Medicine. […]
Read more
COVID-19 survivor donates plasma to help others recover from the virus Jose Abdelnoor, 71, and his wife Evelyn Diaz, 67, say they would go through the scary experience of having COVID-19 again if it means they could save a life through donating their antibody-rich plasma. “What greater gift is there to give someone than human life?” Diaz asked. Abdelnoor donated plasma through an experimental therapy program […]
Read more
First COVID-19 patient in Texas enrolled in UTHealth stem cell therapy study at Memorial Hermann The first COVID-19 patient in Texas has been enrolled in a stem cell therapy clinical trial for acute respiratory distress syndrome (ARDS) at The University of Texas Health Science Center at Houston (UTHealth). The procedure took place April 16, 2020, at Memorial Hermann-Texas Medical Center. ARDS is a serious condition of the lungs, in which […]
Read more
UTHealth, Memorial Hermann seeking plasma donations from survivors of COVID-19 UTHealth and Memorial Hermann are investigating the possibility that plasma from COVID-19 survivors may help patients recover from the virus.
Read more

UTHealth COVID-19 Research

Neurologists test novel compound for lung and brain injury in severe COVID-19 patients